{"transactions":[{"id":4616197,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:13.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":121968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-036378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036378/form4.xml","form_type":"4"}},{"id":4616196,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:13.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":103000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-26-036378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036378/form4.xml","form_type":"4"}},{"id":4616195,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:13.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":103000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.34,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-26-036378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036378/form4.xml","form_type":"4"}},{"id":4616194,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:13.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":1.88,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001140361-26-036378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036378/form4.xml","form_type":"4"}},{"id":4616193,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-11T21:44:13.000Z","date":"2026-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of July 15, 2026, by and among AtaiBeckley Inc. (the \"Company\"), Eli Lilly and Company, an Indiana corporation (\"Parent\"), and Albali Acquisition Corporation, a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"), on September 11, 2026, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each outstanding stock option of the Company, subject to certain exceptions, was automatically cancelled and converted into the right to receive (A) an amount in cash (without interest and less applicable tax withholdings) equal to the product of (1) the total number of shares of the Company's common stock subject to such stock option immediately prior to the Effective Time multiplied by (2) the excess of $6.75 over the applicable exercise price per share under such stock option and (B) one contingent value right per share (each, a \"CVR\" and collectively, the \"CVRs\"), representing the right to receive up to an aggregate of $2.50 in cash per CVR upon achievement, if any, of specified clinical and regulatory milestones, less any applicable tax withholding, for each share subject to such stock option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":3.84,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001140361-26-036378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126036378/form4.xml","form_type":"4"}},{"id":746593,"issuer":{"id":4289,"kind":"organization","name":"AtaiBeckley Inc.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-09T00:00:31.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":121968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before AtaiBeckley Inc.'s next annual meeting or June 4, 2027, subject to continued service on AtaiBeckley Inc.'s board of directors through the applicable vesting date."}],"balance_after":121968,"derivative":{"exercise_price":4.5,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":121968},"source":{"system":"sec-edgar","filing":"0001140361-26-024520","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126024520/form4.xml","form_type":"4"}},{"id":890536,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2026-02-20T21:01:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":21600,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This security is convertible or exercisable, as applicable, at any time after issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This security expires on the 36-month anniversary of the date of issuance."}],"balance_after":21600,"derivative":{"exercise_price":4,"underlying":"Common stock","underlying_shares":21600},"source":{"system":"sec-edgar","filing":"0001199102-26-000004","document":"wk-form4_1771621308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910226000004/wk-form4_1771621308.xml","form_type":"4"}},{"id":890535,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-02-20T21:01:50.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":10800,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This security is convertible or exercisable, as applicable, at any time after issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Convertible Preferred Stock (the Preferred Stock) is perpetual and has no expiration date. The Issuer has the option to redeem the Preferred Stock and the right to require the conversion of the Preferred Stock into shares of the common stock of the Issuer (the Common Stock), in each case, subject to specified conditions."}],"balance_after":10800,"derivative":{"exercise_price":2.5,"underlying":"Common stock","underlying_shares":21600},"source":{"system":"sec-edgar","filing":"0001199102-26-000004","document":"wk-form4_1771621308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910226000004/wk-form4_1771621308.xml","form_type":"4"}},{"id":924772,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-02T21:06:47.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":172000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":172000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-01-30","underlying":"Common stock","underlying_shares":172000},"source":{"system":"sec-edgar","filing":"0001199102-26-000002","document":"wk-form4_1770066405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910226000002/wk-form4_1770066405.xml","form_type":"4"}},{"id":1100064,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-06-27T21:31:27.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 26, 2026."}],"balance_after":103000,"derivative":{"exercise_price":2.25,"expiration_date":"2035-06-26","underlying":"Common Shares","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-25-024021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199102/000114036125024021/form4.xml","form_type":"4"}},{"id":1289338,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T22:31:46.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":107000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":107000,"derivative":{"exercise_price":3.27,"expiration_date":"2035-01-28","underlying":"Common stock","underlying_shares":107000},"source":{"system":"sec-edgar","filing":"0001401914-25-000004","document":"wk-form4_1738362699.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000004/wk-form4_1738362699.xml","form_type":"4"}},{"id":1478734,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-06-14T21:00:38.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or June 13, 2025."}],"balance_after":103000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-06-13","underlying":"Common Shares","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001140361-24-030204","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199102/000114036124030204/form4.xml","form_type":"4"}},{"id":1576477,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-14T20:34:04.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":750000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-03-12","underlying":"Common stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001401914-24-000006","document":"wk-form4_1710448428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191424000006/wk-form4_1710448428.xml","form_type":"4"}},{"id":1877806,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-25T20:24:57.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before the ATAI Life Sciences N.V's next annual meeting or May 16, 2024."}],"balance_after":64000,"derivative":{"exercise_price":1.88,"expiration_date":"2033-05-23","underlying":"Common Shares","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0000950170-23-024253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199102/000095017023024253/ownership.xml","form_type":"4"}},{"id":2044897,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-26T21:07:34.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":750000,"derivative":{"exercise_price":1.16,"expiration_date":"2033-01-24","underlying":"Common stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001401914-23-000008","document":"wf-form4_167476720939649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191423000008/wf-form4_167476720939649.xml","form_type":"4"}},{"id":2252991,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T21:46:12.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest on the earlier of the day before ATAI Life Sciences N.V.'s next annual meeting or May 25, 2023."}],"balance_after":64000,"derivative":{"exercise_price":3.84,"expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0000899243-22-019963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199102/000089924322019963/doc4.xml","form_type":"4"}},{"id":2313486,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-31T22:49:02.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":2430,"price":1.46,"value":3547.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21"}],"balance_after":33642,"source":{"system":"sec-edgar","filing":"0001209191-22-021847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919122021847/doc4.xml","form_type":"4"}},{"id":2422380,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T21:04:13.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":628400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":628400,"derivative":{"exercise_price":1.59,"expiration_date":"2032-01-25","underlying":"Common stock","underlying_shares":628400},"source":{"system":"sec-edgar","filing":"0001401914-22-000008","document":"wf-form4_164340383866492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191422000008/wf-form4_164340383866492.xml","form_type":"4"}},{"id":2455152,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T22:19:45.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":2430,"price":1.86,"value":4519.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21"}],"balance_after":36072,"source":{"system":"sec-edgar","filing":"0001209191-22-000263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919122000263/doc4.xml","form_type":"4"}},{"id":2555203,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T20:41:01.000Z","date":"2021-09-30","kind":"tax_withholding","acquired":false,"shares":2430,"price":3.86,"value":9379.8,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21"}],"balance_after":38502,"source":{"system":"sec-edgar","filing":"0001209191-21-058476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919121058476/doc4.xml","form_type":"4"}},{"id":2571847,"issuer":{"id":72536,"kind":"organization","name":"Atai Beckley N.V.","symbol":"ATAI"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-09-13T20:30:46.000Z","date":"2021-09-10","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest with respect to a third of the underlying common shares on June 17, 2022 and in 24 substantially equal monthly installments thereafter until June 17, 2024."}],"balance_after":128000,"derivative":{"exercise_price":16.46,"expiration_date":"2031-09-10","underlying":"Common Shares","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0000899243-21-035679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199102/000089924321035679/doc4.xml","form_type":"4"}},{"id":2648678,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T20:21:13.000Z","date":"2021-06-30","kind":"tax_withholding","acquired":false,"shares":2430,"price":4.91,"value":11931.3,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21"}],"balance_after":40932,"source":{"system":"sec-edgar","filing":"0001209191-21-044382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919121044382/doc4.xml","form_type":"4"}},{"id":2762643,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T21:35:46.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":24295,"price":2.06,"value":50047.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The RSU's vests in four equal quarterly installments on 6/30/21, 9/30/21, 12/31/21 and 3/31/22."}],"balance_after":43362,"source":{"system":"sec-edgar","filing":"0001209191-21-024734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919121024734/doc4.xml","form_type":"4"}},{"id":2762642,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T21:35:46.000Z","date":"2021-03-31","kind":"tax_withholding","acquired":false,"shares":2575,"price":2.03,"value":5227.25,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20"}],"balance_after":19067,"source":{"system":"sec-edgar","filing":"0001209191-21-024734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919121024734/doc4.xml","form_type":"4"}},{"id":2892027,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T21:05:19.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":525000,"derivative":{"exercise_price":2.59,"expiration_date":"2031-01-26","underlying":"Common stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001199102-21-000005","document":"wf-form4_161186790314013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000119910221000005/wf-form4_161186790314013.xml","form_type":"4"}},{"id":2926596,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T21:09:37.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":2575,"price":2.47,"value":6360.25,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20"}],"balance_after":21642,"source":{"system":"sec-edgar","filing":"0001209191-21-000243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919121000243/doc4.xml","form_type":"4"}},{"id":3019170,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T17:55:33.000Z","date":"2020-09-30","kind":"tax_withholding","acquired":false,"shares":2389,"price":1.35,"value":3225.15,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20"}],"balance_after":24217,"source":{"system":"sec-edgar","filing":"0001209191-20-052568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919120052568/doc4.xml","form_type":"4"}},{"id":3029287,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-17T16:59:07.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSU was granted on 4/3/20, but was contingent on stockholder approval of the Issuer's 2020 Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 9/15/20, and therefore for purposes of Section 16, the RSU was not \"acquired\" until such stockholder approval was obtained. The RSU's vest in two equal installments on 12/31/2020 and 3/31/2021."}],"balance_after":26606,"source":{"system":"sec-edgar","filing":"0001209191-20-050822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919120050822/doc4.xml","form_type":"4"}},{"id":3093696,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T19:11:41.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":2389,"price":2.03,"value":4849.67,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20"}],"balance_after":25677,"source":{"system":"sec-edgar","filing":"0001209191-20-040140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919120040140/doc4.xml","form_type":"4"}},{"id":3181068,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-07T19:21:30.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":23893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The RSU's vests in four equal quarterly installments on 6/30/2020, 9/30/2020, 12/31/2020 and 3/31/2021."}],"balance_after":28066,"source":{"system":"sec-edgar","filing":"0001209191-20-023741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919120023741/doc4.xml","form_type":"4"}},{"id":3187795,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T19:21:35.000Z","date":"2020-03-31","kind":"tax_withholding","acquired":false,"shares":244,"price":1.52,"value":370.88,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19"}],"balance_after":4173,"source":{"system":"sec-edgar","filing":"0001209191-20-022460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919120022460/doc4.xml","form_type":"4"}},{"id":3220260,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chef Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-09T21:43:58.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":280000,"derivative":{"exercise_price":1.03,"expiration_date":"2030-03-06","underlying":"Common stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001401914-20-000034","document":"wf-form4_158379021939186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191420000034/wf-form4_158379021939186.xml","form_type":"4"}},{"id":3328064,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T23:47:21.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":246,"price":0.8439,"value":207.5994,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The end of period holdings reflect a 1-15 reverse stock split effected by the Issuer on October 14, 2019."}],"balance_after":4417,"source":{"system":"sec-edgar","filing":"0001209191-20-000440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919120000440/doc4.xml","form_type":"4"}},{"id":3401865,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:52:09.000Z","date":"2019-09-30","kind":"tax_withholding","acquired":false,"shares":3684,"price":0.235,"value":865.74,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19"}],"balance_after":69944,"source":{"system":"sec-edgar","filing":"0001209191-19-051880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119051880/doc4.xml","form_type":"4"}},{"id":3472895,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T21:17:09.000Z","date":"2019-06-30","kind":"tax_withholding","acquired":false,"shares":3684,"price":0.37,"value":1363.08,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSU's that were originally reported in Table II of the Reporting Person's Form 4 filed 4/3/19."}],"balance_after":73628,"source":{"system":"sec-edgar","filing":"0001209191-19-040462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119040462/doc4.xml","form_type":"4"}},{"id":3528616,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T22:42:59.000Z","date":"2018-03-31","kind":"tax_withholding","acquired":false,"shares":16260,"price":1.19,"value":19349.4,"ownership":{"direct":true},"balance_after":24390,"source":{"system":"sec-edgar","filing":"0001209191-19-029782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119029782/doc4.xml","form_type":"4"}},{"id":3528615,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T22:42:59.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":40650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"RSU was originally reported in Table II of the Reporting Person's Form 3 filed 02/22/2018 which has been amended to remove such award and is being reported herein."}],"balance_after":40650,"source":{"system":"sec-edgar","filing":"0001209191-19-029782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119029782/doc4.xml","form_type":"4"}},{"id":3528614,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T22:31:15.000Z","date":"2019-03-31","kind":"tax_withholding","acquired":false,"shares":3573,"price":0.95,"value":3394.35,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18"}],"balance_after":40470,"source":{"system":"sec-edgar","filing":"0001209191-19-029772","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119029772/doc5.xml","form_type":"5"}},{"id":3528613,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T22:31:15.000Z","date":"2018-12-31","kind":"tax_withholding","acquired":false,"shares":3573,"price":1.3,"value":4644.9,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18"}],"balance_after":44043,"source":{"system":"sec-edgar","filing":"0001209191-19-029772","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119029772/doc5.xml","form_type":"5"}},{"id":3528612,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T22:31:15.000Z","date":"2018-09-30","kind":"tax_withholding","acquired":false,"shares":3573,"price":1.18,"value":4216.14,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18"}],"balance_after":47616,"source":{"system":"sec-edgar","filing":"0001209191-19-029772","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119029772/doc5.xml","form_type":"5"}},{"id":3528628,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-14T22:27:58.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":26799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This amendment is being filed to correct the grant date of the 26,799 share RSU.  The RSU was originally reported in Table II of the Reporting Person's Form 4 filed 7/31/2018."}],"balance_after":51189,"source":{"system":"sec-edgar","filing":"0001209191-19-029766","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119029766/doc4a.xml","form_type":"4/A","original_submission_date":"2018-07-31"}},{"id":3566619,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSU)","published_at":"2019-04-03T19:21:46.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":36842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vests in four equal quarterly installments on 6/30/19, 9/30/19, 12/31/19 and 3/31/20."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vests in four equal quarterly installments on 6/30/19, 9/30/19, 12/31/19 and 3/31/20."}],"balance_after":36842,"derivative":{"underlying":"Common Stock","underlying_shares":36842},"source":{"system":"sec-edgar","filing":"0001209191-19-023056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919119023056/doc4.xml","form_type":"4"}},{"id":3681159,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-31T22:30:03.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":195000,"derivative":{"exercise_price":0.759,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001209191-19-006215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919119006215/doc4.xml","form_type":"4"}},{"id":3820486,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-10T22:22:44.000Z","date":"2018-09-07","kind":"grant","acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":192000,"derivative":{"exercise_price":1.01,"expiration_date":"2028-09-07","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001209191-18-050350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919118050350/doc4.xml","form_type":"4"}},{"id":3858324,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-08-01T01:15:52.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":26799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"40,650 restricted stock units vested on 3/31/2018. 26,799 restricted stock units to vest ratably on 9/30/18, 12/31/18 and 3/31/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"40,650 restricted stock units vested on 3/31/2018. 26,799 restricted stock units to vest ratably on 9/30/18, 12/31/18 and 3/31/19."}],"balance_after":67449,"derivative":{"underlying":"Common Stock","underlying_shares":26799},"source":{"system":"sec-edgar","filing":"0001683168-18-002082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000168316818002082/ownership.xml","form_type":"4"}},{"id":4251819,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":40591,"kind":"person","name":"JOHNSON SABRINA MARTUCCI","position":1,"cik":"0001199102","reported_name":"JOHNSON SABRINA MARTUCCI","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-25T20:20:28.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":962062,"ownership":{"direct":false,"nature":"By The Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 4, 2005"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the \"Corporation\"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. (\"Dare Operations\") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the \"Transaction\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 4,739,295 shares of Dare Operations common stock. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis)."}],"balance_after":962062,"source":{"system":"sec-edgar","filing":"0001209191-17-046159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117046159/doc4.xml","form_type":"4"}}]}